Infosys has been rated as a leader and star performer in life sciences IT outsourcing (ITO) in the Everest Group Peak Matrix Assessment 2014.

The Bengaluru-based company which is already a global leader in consulting, technology and outsourcing solutions has now been recognized for its contribution in the Everest Group report on IT outsourcing in life sciences industry– service provider landscape with Peak Matrix Assessment 2014.

The Everest Peak Matrix for Life Sciences had evaluated 18 IT services providers, selected on the basis of their success in large life sciences ITO relationships. Service providers were grouped into three high-level categories based on their capability, service offerings and market success.

Infosys scored high in terms of the size and growth of its life sciences revenues in 2013, global delivery capability and overall market success. This was aided by investments in proprietary solutions and an expanding portfolio of offerings in the life sciences space. This portfolio includes solutions that support drug discovery, clinical trials, sales force effectiveness, digital marketing, ERP, supply chain transformation, management of complex compliance processes and solutions to track and trace. Infosys’ clients in the sector include global and mid-sized pharmaceutical companies, biotech organizations, medical devices manufacturers, and drug distributors.

“The life sciences industry is operating in a dynamic landscape today with heightened regulatory scrutiny, patent cliffs, and growing incidence of mergers and acquisitions. Technology can play an important role to help life sciences companies embrace these changes and stay competitive. For example, Infosys recently launched a cloud-based solution to help enterprises in this industry reduce costs of regulatory compliance and clinical trial management while accelerating business processes,” said Manish Tandon, executive vice president and global head, life sciences & services, Infosys.

According to Jimit Arora, vice president, Everest Group, the surge in life sciences in ITO is driven by application portfolio modernization, infrastructure transformation, and analytics. Life sciences enterprises are looking at service providers to provide a blend of traditional and next-generation services. In the past year, Infosys has made investments to create a balanced portfolio of offerings across traditional and next-generation services. This has resulted in significant market success in large life sciences ITO contracts for it which contributed to the rating of Leader and Star Performer.